Ligand to Report Second Quarter 2019 Results on July 30th

Go back to Ligand to Report Second Quarter 2019 Results on July 30th
LIGAND PHARMA (NASDAQ: LGND) Delayed: 289.07 -1.64 (0.56%)
Previous Close $290.71    52 Week High $139.79 
Open $289.11    52 Week Low $82.07 
Day High $293.37    P/E 672.26 
Day Low $287.81    EPS $0.43 
Volume 10,641